Development of a Tetrahymena thermophila-Based Vaccine Expressing Miamiensis avidus Ciliary Proteins to Combat Scuticociliatosis

IF 2.2 3区 农林科学 Q2 FISHERIES Journal of fish diseases Pub Date : 2025-02-09 DOI:10.1111/jfd.14097
Yuho Watanabe, Maho Kotake, Hiromi Matsuoka, Tomoyoshi Yoshinaga, Shin-Ichi Kitamura
{"title":"Development of a Tetrahymena thermophila-Based Vaccine Expressing Miamiensis avidus Ciliary Proteins to Combat Scuticociliatosis","authors":"Yuho Watanabe,&nbsp;Maho Kotake,&nbsp;Hiromi Matsuoka,&nbsp;Tomoyoshi Yoshinaga,&nbsp;Shin-Ichi Kitamura","doi":"10.1111/jfd.14097","DOIUrl":null,"url":null,"abstract":"<p><i>Miamiensis avidus</i> is a parasitic pathogen responsible for scuticociliatosis, a lethal infection affecting marine fish worldwide, including Japanese flounder. Immunisation with formalin-killed <i>M. avidus</i> has shown promise in inducing protective immunity, positioning it as a potential vaccine candidate against scuticociliatosis. However, challenges such as the high cost of producing sufficient cells and inconsistent quality due to the lack of cryopreservation methods hinder its development. In this study, we expressed <i>M. avidus</i> ciliary proteins in <i>Tetrahymena</i>, a culturable ciliate, and used these cells to immunise Japanese flounder. The immunised fish produced antibodies against <i>M. avidus</i>. Additionally, immunisation with two transgenic <i>Tetrahymena</i> strains, each expressing different ciliary proteins, induced the production of antibodies against two serotypes of the parasite. In challenge experiments, fish immunised with the transgenic <i>Tetrahymena</i> showed prolonged survival compared to the control group, highlighting the potential of this approach as a vaccine candidate. These findings suggest that transgenic <i>Tetrahymena</i> cells could be a viable platform for developing vaccines against multiple serotypes of <i>M. avidus</i>.</p>","PeriodicalId":15849,"journal":{"name":"Journal of fish diseases","volume":"48 6","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jfd.14097","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of fish diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jfd.14097","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FISHERIES","Score":null,"Total":0}
引用次数: 0

Abstract

Miamiensis avidus is a parasitic pathogen responsible for scuticociliatosis, a lethal infection affecting marine fish worldwide, including Japanese flounder. Immunisation with formalin-killed M. avidus has shown promise in inducing protective immunity, positioning it as a potential vaccine candidate against scuticociliatosis. However, challenges such as the high cost of producing sufficient cells and inconsistent quality due to the lack of cryopreservation methods hinder its development. In this study, we expressed M. avidus ciliary proteins in Tetrahymena, a culturable ciliate, and used these cells to immunise Japanese flounder. The immunised fish produced antibodies against M. avidus. Additionally, immunisation with two transgenic Tetrahymena strains, each expressing different ciliary proteins, induced the production of antibodies against two serotypes of the parasite. In challenge experiments, fish immunised with the transgenic Tetrahymena showed prolonged survival compared to the control group, highlighting the potential of this approach as a vaccine candidate. These findings suggest that transgenic Tetrahymena cells could be a viable platform for developing vaccines against multiple serotypes of M. avidus.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以嗜热四膜虫为基础,表达嗜热迈阿密虫纤毛蛋白的疫苗的研制。
Miamiensis avidus是一种寄生病原体,负责scuticoiliatosis,一种影响全球海洋鱼类的致命感染,包括日本比目鱼。用福尔马林杀死的金黄色分枝杆菌进行免疫接种已显示出诱导保护性免疫的希望,使其成为一种潜在的抗角膜炎的候选疫苗。然而,诸如生产足够细胞的高成本和由于缺乏冷冻保存方法而导致的质量不稳定等挑战阻碍了其发展。在本研究中,我们在可培养的纤毛虫四膜虫中表达了avidus纤毛蛋白,并利用这些细胞免疫了日本比目鱼。免疫后的鱼产生了抗黑弧菌的抗体。此外,用两种表达不同纤毛蛋白的转基因四膜虫菌株免疫,诱导产生针对两种血清型寄生虫的抗体。在挑战实验中,与对照组相比,用转基因四膜虫免疫的鱼表现出更长的存活时间,突出了这种方法作为候选疫苗的潜力。这些发现表明,转基因四膜虫细胞可能是开发针对多种血清型猪分枝杆菌疫苗的可行平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of fish diseases
Journal of fish diseases 农林科学-海洋与淡水生物学
CiteScore
4.60
自引率
12.00%
发文量
170
审稿时长
6 months
期刊介绍: Journal of Fish Diseases enjoys an international reputation as the medium for the exchange of information on original research into all aspects of disease in both wild and cultured fish and shellfish. Areas of interest regularly covered by the journal include: -host-pathogen relationships- studies of fish pathogens- pathophysiology- diagnostic methods- therapy- epidemiology- descriptions of new diseases
期刊最新文献
Comparative Evaluation of Oral Biofilm and Killed Cell Vaccines Against Streptococcus iniae in Four-Finger Threadfin Fish (Eleutheronema tetradactylum): Immune Response and Protection Efficacy. Laboratory Transmission of Adult Salmon Enteritis and Associated Pathogens in Juvenile Chinook Salmon (Oncorhynchus tshawytscha). Fatal Hemorrhagic Septicemia in Common Guitarfish (Rhinobatos rhinobatos) Caused by Photobacterium damselae Subsp. damselae in a Controlled Environment. Transcriptome Analysis of Penaeus vannamei Hepatopancreas in Response to Lactococcus garvieae Infection in Low Salinity. Opercular Shortening and Deformities in Farmed Atlantic Salmon (Salmo salar) and Rainbow Trout (Oncorhynchus mykiss)-A Qualitative Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1